PE20090767A1 - Formulaciones de inmunoglobulina liofilizadas y metodos para su preparacion - Google Patents
Formulaciones de inmunoglobulina liofilizadas y metodos para su preparacionInfo
- Publication number
- PE20090767A1 PE20090767A1 PE2008001028A PE2008001028A PE20090767A1 PE 20090767 A1 PE20090767 A1 PE 20090767A1 PE 2008001028 A PE2008001028 A PE 2008001028A PE 2008001028 A PE2008001028 A PE 2008001028A PE 20090767 A1 PE20090767 A1 PE 20090767A1
- Authority
- PE
- Peru
- Prior art keywords
- lyophilized
- formulation
- preparation
- methods
- amount
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 2
- 102000018358 immunoglobulin Human genes 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 229960005027 natalizumab Drugs 0.000 abstract 2
- 238000009825 accumulation Methods 0.000 abstract 1
- 239000013011 aqueous formulation Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 239000012931 lyophilized formulation Substances 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 229950008882 polysorbate Drugs 0.000 abstract 1
- 229920000053 polysorbate 80 Polymers 0.000 abstract 1
- 229940068968 polysorbate 80 Drugs 0.000 abstract 1
- 239000008181 tonicity modifier Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92913307P | 2007-06-14 | 2007-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090767A1 true PE20090767A1 (es) | 2009-06-24 |
Family
ID=40897430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001028A PE20090767A1 (es) | 2007-06-14 | 2008-06-16 | Formulaciones de inmunoglobulina liofilizadas y metodos para su preparacion |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR067010A1 (zh) |
| CL (1) | CL2008001778A1 (zh) |
| PE (1) | PE20090767A1 (zh) |
| TW (1) | TW200909005A (zh) |
| ZA (1) | ZA200909090B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021551916A1 (en) * | 2019-02-18 | 2022-05-23 | Lilly Co Eli | Therapeutic antibody formulation. |
-
2008
- 2008-06-13 TW TW97122278A patent/TW200909005A/zh unknown
- 2008-06-13 AR ARP080102544 patent/AR067010A1/es unknown
- 2008-06-16 CL CL2008001778A patent/CL2008001778A1/es unknown
- 2008-06-16 PE PE2008001028A patent/PE20090767A1/es not_active Application Discontinuation
-
2009
- 2009-01-01 ZA ZA200909090A patent/ZA200909090B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200909090B (en) | 2010-08-25 |
| CL2008001778A1 (es) | 2008-12-19 |
| AR067010A1 (es) | 2009-09-30 |
| TW200909005A (en) | 2009-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011001406A1 (es) | “formulación farmacéutica líquida estable que comprende un anticuerpo para il-1beta (acz885), manitol, tampón de histidina y polisorbato 80, con un ph entre 5,5-7,0”. | |
| CO6251275A2 (es) | Formulaciones de inmunoglobulina liofilizadas y metodos para su preparacion | |
| AR130402A2 (es) | Formulaciones de anticuerpos anti-pdl1 | |
| EA200870538A1 (ru) | Лиофилизированные композиции анти-egfr антител | |
| AR071852A1 (es) | Formulacion farmaceutica de un anticuerpo frente a ox40l | |
| AR074427A1 (es) | Composiciones estables de anticuerpos y metodos para estabilizarlas | |
| ES2531385T3 (es) | Formulación que comprende un anticuerpo contra la selectina P | |
| EA200800233A1 (ru) | Композиция иммуноконьюгата | |
| CO5660273A2 (es) | Formulaciones de proteina y anticuerpo de alta concentracion | |
| CL2012001966A1 (es) | Formulación farmacéutica que comprende entre 100-150 mg/ml de un anticuerpo que se une específicamente al receptor a de il-17 humana, una solución acuosa de un buffer 5-30 mm de ácido glutámico ph 4,5-5,2, prolina 2-4% p/v y polisorbato-20 0,005-0,02% p/v; envase farmacéutico y kit que comprende dicha formulación; y su uso para tratar psoriasis. | |
| CO2019009034A2 (es) | Formulación de anticuerpo monoclonal anti-vrs referencia cruzada a solicitudes relacionadas | |
| AR079556A1 (es) | Formacion de anticuerpos | |
| CL2008001984A1 (es) | Formulacion de anticuerpo anti-cd20; y su uso para tratar enfermedades que implican celulas que expresan cd20 en un mamifero. | |
| BR112021017890A2 (pt) | Composição líquida compreendendo um anticorpo do receptor alfa de interleucina-4 humana | |
| MX363380B (es) | Formulacion de anticuerpos. | |
| MY146100A (en) | Antibody formulations | |
| EA200970880A1 (ru) | Стабильные композиции на основе антител | |
| AR092401A1 (es) | Formulaciones de anticuerpos anti-receptor de prolactina (anti-prlr) | |
| TN2012000023A1 (en) | Subcutaneous anti-her2 antibody formulation | |
| MY197773A (en) | Highly concentrated pharmaceutical formulations comprising anti-cd20 antibody | |
| PE20191242A1 (es) | Formulaciones de anticuerpo y metodos | |
| AR047611A1 (es) | Formulaciones liquidas de anticuerpos anti-egfr altamente concentradas | |
| PE20151524A1 (es) | FORMULACIONES DE LA SOLUCION DE LOS ANTICUERPOS ANTI-IL-23p19 MANIPULADOS GENETICAMENTE | |
| ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
| BRPI0607349A2 (pt) | combinação de xolair com agente imunossupressor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |